1. Association study of lamotrigine-induced cutaneous adverse reactions and HLA-B*1502 in a Han Chinese population
- Author
-
An, Dong-Mei, Wu, Xin-Tong, Hu, Fa-Yun, Yan, Bo, Stefan, Hermann, and Zhou, Dong
- Subjects
- *
LAMOTRIGINE , *ANTICONVULSANTS , *DRUG side effects , *CARBAMAZEPINE , *HLA histocompatibility antigens , *TOXIC epidermal necrolysis , *STEVENS-Johnson Syndrome - Abstract
Summary: Antiepileptic drugs including lamotrigine (LTG) and carbamazepine (CBZ) are among the most common causes of cutaneous adverse reactions (cADRs). Human leukocyte antigen (HLA)-B*1502 has been strongly associated with CBZ-induced Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). To investigate this relationship, we performed high-resolution HLA genotyping on LTG-tolerant controls, healthy volunteers, and patients affected by LTG-induced cADRs, ranging from maculopapular exanthema (MPE) to SJS/TEN. Patients with LTG-induced cADRs (n =25, including three with SJS/TEN and 22 with MPE), 21 LTG-tolerant controls, and 71 healthy volunteers were enrolled. The differences in the starting dosage of LTG among the SJS/TEN, MPE, and LTG-tolerant control groups were not statistically significant. HLA-B*1502 frequency was 33.3% (1/3; LTG-induced SJS/TEN group), 9.1% (2/22; LTG-induced MPE group), 4.8% (1/21; LTG-tolerant group), and 8.5% (6/71; healthy volunteers). There was no significant difference in the frequency of subjects with the HLA-B*1502 allele between the SJS/TEN group and LTG-tolerant group (p =0.239, OR=10.0, 95% CI 0.44–228.7), and healthy volunteers (p =0.26, OR=5.42, 95% CI 0.43–68.8), MPE and LTG-tolerant groups (p =1.0, OR=1.08, 95% CI 0.20–5.8), and healthy volunteers (p =1.0, OR=2.0, 95% CI 0.17–23.9). None of the HLA alleles detected were associated with LTG-induced cADRs. In conclusion, HLA-B*1502 and other HLA alleles are not directly associated with LTG-induced MPE. The possibility that HLA-B*1502 is associated with an increased risk of LTG-induced SJS/TEN could not be excluded. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF